Seppic has released the results of a study that demonstrates that liquid crystals are the secret behind Montanov 202's performance in formulation and skin benefits.
Historically it is recognised that Montanov 202's unique properties are mainly due to the presence of liquid crystals in the emulsions. This year, using the latest technologies, Seppic went further and conducted studies to understand the mechanism of action behind those skin benefits but also to demonstrate that these structures are robust.
First Montanov 202 emulsion's richness in liquid crystals was investigated to understand the impact of time, temperature, transport and formulation composition on the creation and the stability of lamellar phases and lamellar bilayers. Extensive stability studies mimicking extreme conditions, such as hot temperature and transportation, demonstrated that Montanov 202 can easily create liquid crystals that are robust, thus guaranteeing stability and performance over time.
Second, a focus was made on skin improvement. Great similarities were found between the emulsion and the stratum corneum lipid organisations. X-ray microdiffraction proved that the lamellar bilayer biomimetic structure in the emulsion strengthens the skin barrier function by gently inserting itself within the stratum corneum lipids lamellar structure. As a result, skin roughness is immediately reduced and skin moisturisation is increased for up to five hours after application, in vivo demonstration by visualisation imaging technology and corneometry measurement. The skin is visibly smoother!
Léa Couillault, product manager, stated: “Montanov 202 is a natural O/W emulsifier formulating ultra white thick lotions to creams with a light, soft skin-feel and a matte finish on the skin. Emulsions are rich in liquid crystals, making them biocompatible and able to bring additional activity to the skin. Benefits that are key both for formulators and customers all over the globe.”
See more about SEPPIC | Air Liquide Healthcare Specialty Ingredients
